{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:59:30Z","timestamp":1793289570306,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.lfs.2023.122342","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T01:58:24Z","timestamp":1702259904000},"page":"122342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Beta-lapachone ameliorates the progression of primary sclerosing cholangitis pathogenesis in rodent models"],"prefix":"10.1016","volume":"337","author":[{"given":"Seung Hee","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Je","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongsu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Sik","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heedoo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Hwan","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10139","key":"10.1016\/j.lfs.2023.122342_bb0005","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lfs.2023.122342_bb0010","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cld.902","article-title":"Primary sclerosing cholangitis: epidemiology, genetics, diagnosis, and current management","volume":"15","author":"Gochanour","year":"2020","journal-title":"Clin. Liver Dis."},{"issue":"6","key":"10.1016\/j.lfs.2023.122342_bb0015","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jhep.2014.02.006","article-title":"Characterization of animal models for primary sclerosing cholangitis (PSC)","volume":"60","author":"Fickert","year":"2014","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122342_bb0020","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","article-title":"Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management","volume":"145","author":"Eaton","year":"2013","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.lfs.2023.122342_bb0025","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.lfs.2023.122342_bb0030","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1477-7819-12-164","article-title":"Secondary bile acids: an underrecognized cause of colon cancer","volume":"12","author":"Ajouz","year":"2014","journal-title":"World J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.lfs.2023.122342_bb0035","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.lfs.2023.122342_bb0040","article-title":"Glucocorticosteroids for primary sclerosing cholangitis","volume":"2010","author":"Giljaca","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.lfs.2023.122342_bb0045","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/jlts.2003.50143","article-title":"Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation","volume":"9","author":"Kugelmas","year":"2003","journal-title":"Liver Transpl."},{"issue":"8","key":"10.1016\/j.lfs.2023.122342_bb0050","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1365-2036.2005.02407.x","article-title":"Review article: current management of primary sclerosing cholangitis","volume":"21","author":"Cullen","year":"2005","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.lfs.2023.122342_bb0055","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/apt.14540","article-title":"Review article: the evidence that vancomycin is a therapeutic option for primary sclerosing cholangitis","volume":"47","author":"Damman","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.lfs.2023.122342_bb0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.lfs.2023.122342_bb0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","article-title":"A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis","volume":"73","author":"Kowdley","year":"2020","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.lfs.2023.122342_bb0070","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1073\/pnas.1417921112","article-title":"In vivo NAD assay reveals the intracellular NAD contents and redox state in healthy human brain and their age dependences","volume":"112","author":"Zhu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.lfs.2023.122342_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008170","article-title":"NAD(+) redox imbalance in the heart exacerbates diabetic cardiomyopathy","volume":"14","author":"Chiao","year":"2021","journal-title":"Circ. Heart Fail."},{"issue":"4","key":"10.1016\/j.lfs.2023.122342_bb0080","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.cmet.2011.08.014","article-title":"Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice","volume":"14","author":"Yoshino","year":"2011","journal-title":"Cell Metab."},{"issue":"6292","key":"10.1016\/j.lfs.2023.122342_bb0085","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1126\/science.aaf2693","article-title":"NAD(+) repletion improves mitochondrial and stem cell function and enhances life span in mice","volume":"352","author":"Zhang","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.lfs.2023.122342_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112962","article-title":"A comprehensive review on beta-lapachone: mechanisms, structural modifications, and therapeutic potentials","volume":"210","author":"Gong","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"44","key":"10.1016\/j.lfs.2023.122342_bb0095","doi-asserted-by":"crossref","first-page":"18203","DOI":"10.1074\/jbc.M117.813923","article-title":"The NQO1 bioactivatable drug, beta-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism","volume":"292","author":"Silvers","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.lfs.2023.122342_bb0100","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2337\/db08-1183","article-title":"Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice","volume":"58","author":"Hwang","year":"2009","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.lfs.2023.122342_bb0105","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCRESAHA.108.189837","article-title":"Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation","volume":"104","author":"Kim","year":"2009","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.122342_bb0110","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cvr\/cvr110","article-title":"Activation of NAD(P)H:quinone oxidoreductase ameliorates spontaneous hypertension in an animal model via modulation of eNOS activity","volume":"91","author":"Kim","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.lfs.2023.122342_bb0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.toxlet.2013.06.239","article-title":"Protective role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in cisplatin-induced nephrotoxicity","volume":"221","author":"Gang","year":"2013","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.lfs.2023.122342_bb0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/ajh\/hpu116","article-title":"NAD(P)H:quinone oxidoreductase 1 activation reduces blood pressure through regulation of endothelial nitric oxide synthase acetylation in spontaneously hypertensive rats","volume":"28","author":"Kim","year":"2015","journal-title":"Am. J. Hypertens."},{"issue":"1","key":"10.1016\/j.lfs.2023.122342_bb0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13578-023-01065-9","article-title":"CrebH protects against liver injury associated with colonic inflammation via modulation of exosomal miRNA","volume":"13","author":"Lee","year":"2023","journal-title":"Cell Biosci."},{"issue":"6","key":"10.1016\/j.lfs.2023.122342_bb0130","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J. Hepatol."},{"issue":"21","key":"10.1016\/j.lfs.2023.122342_bb0135","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.3748\/wjg.14.3350","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"14","author":"Chapman","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.lfs.2023.122342_bb0140","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","article-title":"Targeting the gut-liver axis in liver disease","volume":"67","author":"Wiest","year":"2017","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.lfs.2023.122342_bb0145","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.202","article-title":"beta-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells","volume":"5","author":"Park","year":"2014","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.lfs.2023.122342_bb0150","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1073\/pnas.0538044100","article-title":"Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancer","volume":"100","author":"Li","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2023.122342_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1137034","article-title":"Etiology of end-stage liver cirrhosis impacts hepatic natural killer cell heterogenicity","volume":"14","author":"Maretti-Mira","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2023.122342_bb0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hep4.1809","article-title":"Induced pluripotent stem cells from subjects with primary sclerosing cholangitis develop a senescence phenotype following biliary differentiation","volume":"6","author":"Jalan-Sakrikar","year":"2022","journal-title":"Hepatol. Commun."},{"issue":"5","key":"10.1016\/j.lfs.2023.122342_bb0165","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1186\/1479-7364-5-5-485","article-title":"The human sirtuin family: evolutionary divergences and functions","volume":"5","author":"Vassilopoulos","year":"2011","journal-title":"Hum. Genomics"},{"issue":"10","key":"10.1016\/j.lfs.2023.122342_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.564","article-title":"SIRT3 protects hepatocytes from oxidative injury by enhancing ROS scavenging and mitochondrial integrity","volume":"8","author":"Liu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2023.122342_bb0175","article-title":"Melatonin ameliorates myocardial ischemia\/reperfusion injury in type 1 diabetic rats by preserving mitochondrial function: role of AMPK-PGC-1alpha-SIRT3 signaling","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2023.122342_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104739","article-title":"A machine learning-driven study indicates emodin improves cardiac hypertrophy by modulation of mitochondrial SIRT3 signaling","volume":"155","author":"Gao","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.lfs.2023.122342_bb0185","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1055\/s-0030-1253223","article-title":"The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects","volume":"30","author":"Davit-Spraul","year":"2010","journal-title":"Semin. Liver Dis."},{"issue":"3","key":"10.1016\/j.lfs.2023.122342_bb0190","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","article-title":"Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease","volume":"75","author":"Smit","year":"1993","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.lfs.2023.122342_bb0195","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","article-title":"The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood","volume":"120","author":"Jacquemin","year":"2001","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.lfs.2023.122342_bb0200","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.dld.2012.08.011","article-title":"ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population","volume":"45","author":"Anzivino","year":"2013","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.lfs.2023.122342_bb0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-2-29","article-title":"Low phospholipid associated cholelithiasis: association with mutation in the MDR3\/ABCB4 gene","volume":"2","author":"Rosmorduc","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.lfs.2023.122342_bb0210","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/hep.26894","article-title":"Peroxisome proliferator-activated receptor alpha activates human multidrug resistance transporter 3\/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion","volume":"59","author":"Ghonem","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.lfs.2023.122342_bb0215","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3892\/etm.2020.8860","article-title":"SIRT3 is a downstream target of PPAR-alpha implicated in high glucose-induced cardiomyocyte injury in AC16 cells","volume":"20","author":"Zong","year":"2020","journal-title":"Exp. Ther. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523009773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320523009773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T21:13:01Z","timestamp":1758402781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320523009773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":43,"alternative-id":["S0024320523009773"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122342","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beta-lapachone ameliorates the progression of primary sclerosing cholangitis pathogenesis in rodent models","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2023.122342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"122342"}}